###begin article-title 0
###xml 43 49 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Aldo Keto Reductase 1B7 and Prostaglandin F2alpha Are Regulators of Adrenal Endocrine Functions
###end article-title 0
###begin p 1
Conceived and designed the experiments: SLL JCP AMLM AM. Performed the experiments: SLL JCP AMLM FV MM FC PV ISB EL CD. Analyzed the data: SLL JCP AMLM FV HL YU. Contributed reagents/materials/analysis tools: BR YU. Wrote the paper: AM.
###end p 1
###begin p 2
###xml 15 21 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 26 32 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 278 284 270 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 351 359 339 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 574 580 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 696 702 680 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 774 780 754 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 900 906 876 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1082 1088 1054 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1198 1204 1166 1168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1260 1267 1224 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 1293 1299 1257 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1324 1330 1284 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1416 1422 1372 1374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1581 1587 1533 1535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 506 511 <span type="species:ncbi:9606">human</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Prostaglandin F2alpha (PGF2alpha), represses ovarian steroidogenesis and initiates parturition in mammals but its impact on adrenal gland is unknown. Prostaglandins biosynthesis depends on the sequential action of upstream cyclooxygenases (COX) and terminal synthases but no PGF2alpha synthases (PGFS) were functionally identified in mammalian cells. In vitro, the most efficient mammalian PGFS belong to aldo-keto reductase 1B (AKR1B) family. The adrenal gland is a major site of AKR1B expression in both human (AKR1B1) and mouse (AKR1B3, AKR1B7). Thus, we examined the PGF2alpha biosynthetic pathway and its functional impact on both cortical and medullary zones. Both compartments produced PGF2alpha but expressed different biosynthetic isozymes. In chromaffin cells, PGF2alpha secretion appeared constitutive and correlated to continuous expression of COX1 and AKR1B3. In steroidogenic cells, PGF2alpha secretion was stimulated by adrenocorticotropic hormone (ACTH) and correlated to ACTH-responsiveness of both COX2 and AKR1B7/B1. The pivotal role of AKR1B7 in ACTH-induced PGF2alpha release and functional coupling with COX2 was demonstrated using over- and down-expression in cell lines. PGF2alpha receptor was only detected in chromaffin cells, making medulla the primary target of PGF2alpha action. By comparing PGF2alpha-responsiveness of isolated cells and whole adrenal cultures, we demonstrated that PGF2alpha repressed glucocorticoid secretion by an indirect mechanism involving a decrease in catecholamine release which in turn decreased adrenal steroidogenesis. PGF2alpha may be regarded as a negative autocrine/paracrine regulator within a novel intra-adrenal feedback loop. The coordinated cell-specific regulation of COX2 and AKR1B7 ensures the generation of this stress-induced corticostatic signal.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 358 361 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Hyndman1">[1]</xref>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Srivastava1">[2]</xref>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
The aldose reductases (AKR1Bs) belong to the aldo-keto reductase (AKR) superfamily that contains more than 114 proteins expressed in prokaryotes and eukaryotes. This superfamily performs oxidoreduction of a wide variety of endogenous and exogenous substrates including aldoses, aliphatic and aromatic aldehydes and ketones, monosacharides and prostaglandins [1]. Among the 12 members of the AKR1B subfamily, aldose reductase (AKR1B1 in human and AKR1B3 in mouse) has been a focus of interest because of its role in the development of secondary diabetic complications but its physiological functions remain poorly understood [2].
###end p 4
###begin p 5
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Akr1b3</italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ho1">[3]</xref>
###xml 107 110 107 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Aida1">[4]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Yang1">[5]</xref>
###xml 273 281 273 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-VanderJagt1">[6]</xref>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Matsuura1">[7]</xref>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 702 705 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Taragnat1">[8]</xref>
###xml 707 710 707 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Pailhoux1">[9]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Donohue1">[10]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Cao1">[11]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Hyndman2">[12]</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 740 746 <span type="species:ncbi:10090">murine</span>
###xml 802 807 <span type="species:ncbi:9606">human</span>
Aldose reductase deficient mice (Akr1b3-/-) exhibit a partially defective urine-concentrating ability [3], [4] and renal structural abnormalities [5]. AKR1B1/B3 is also present in a broad range of tissues and other physiological functions based on its enzymatic activities in vitro have been proposed. Notably, AKR1B1/B3 is thought to be involved in detoxification of harmful cellular metabolites including 4-hydroxynonenal [6] and isocaproaldehyde [7]. But this function remains to be demonstrated in vivo since AKR1B3 deficient mice appeared to be healthy. It is likely that the detoxification function may be taken over by other AKR1B subfamily members. Indeed, we and others have identified AKR1B7 [8], [9] and AKR1B8 [10] as two other murine members of the family and AKR1B10 has been isolated in human small intestine [11], [12].
###end p 5
###begin p 6
###xml 81 93 81 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vas deferens</italic>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Martinez1">[13]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Tirard1">[19]</xref>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Akr1b7</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Aigueperse1">[20]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Aigueperse2">[21]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Val1">[22]</xref>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez2">[24]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Madore1">[25]</xref>
###xml 747 753 743 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 835 843 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1010 1011 1002 1003 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1016 1017 1008 1009 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1027 1033 1019 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1111 1115 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Kabututu1">[26]</xref>
###xml 214 220 <span type="species:ncbi:10090">murine</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
###xml 505 511 <span type="species:ncbi:10090">murine</span>
###xml 661 667 <span type="species:ncbi:9913">bovine</span>
AKR1B7 presents two interesting characteristics: a tissue-restricted expression (vas deferens, steroidogenic tissues, small intestine and adipose tissue) and a tissue-specific hormonal regulation [13]-[19]. In the murine adrenal cortex, the Akr1b7 gene is up-regulated at the transcriptional level by ACTH [20], [21], [22] and acts as a major reductase for isocaproaldehyde formed during steroidogenesis [23]. In human adrenocortical cells, AKR1B1 was proposed to undertake the same function as AKR1B7 in murine species, based on its hormonal sensitivity and isocaproaldehyde reductase activity [24]. Interestingly, Madore and colleagues [25] proposed that the bovine 20alpha-hydroxysteroid dehydrogenase also known as AKR1B5 had a prostaglandin F2alpha synthase (PGFS) activity in the endometrium. Furthermore, we have established by in vitro studies, that this property can be extended to other but not all AKR1B enzymes since AKR1B1, AKR1B3 and AKR1B7 were shown to catalyze the reduction of prostaglandin H2 (PGH2) into PGF2alpha whereas AKR1B8 and AKR1B10 recombinant proteins were devoid of such activity [26]. Importantly, based on their kinetic parameters, recombinant AKR1B1, AKR1B3 and AKR1B7 display better PGFS activities than the putative PGFS that were previously characterized in mammals.
###end p 6
###begin p 7
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ramsay1">[27]</xref>
###xml 761 767 761 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 877 881 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-McCracken1">[28]</xref>
###xml 1008 1014 1004 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1085 1091 1077 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1247 1253 1235 1237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1349 1353 1333 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ueno1">[29]</xref>
###xml 1355 1359 1339 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Fortier1">[30]</xref>
###xml 1544 1550 1528 1530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Prostaglandins are paracrine/autocrine cell mediators sharing a common precursor, PGH2, which is synthesized from free arachidonic acid by the cyclooxygenases type 1 (COX1) or type 2 (COX2). COX1 is regarded as a constitutively expressed enzyme. COX2 on the other hand is undetectable in most tissues in basal conditions but can be induced by various mitogenic agents and inflammatory stimuli (for review see [27]). These different regulations imply that COX1- and COX2-dependent PG productions will be primarily required for housekeeping functions and rapid adaptation to various stimuli, respectively. However, the identity and regulation of downstream enzymes involved in the selective production of each isotype of prostaglandins remain largely unknown. PGF2alpha is the main initiator of labour and regression of corpus luteum (luteolysis) in most mammals (for review see [28]). Two of the hallmarks features of luteolysis are the decrease in progesterone synthesis and programmed luteal cell death. PGF2alpha-induced inhibition of progesterone biosynthesis is mediated by the PGF2alpha receptor (FP receptor) present in luteal cells. Although it has a primary role in reproductive function, the cellular and molecular mechanisms by which PGF2alpha is produced in living cells and its role in other steroidogenic tissues remain largely unknown [29], [30]. AKR1Bs with PGFS activity are highly expressed and for some of them specifically regulated in the adrenal cortex. We thus decided to explore the capacity of the adrenal to produce PGF2alpha and to investigate the effect that this production has on the endocrine functions of the gland.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Hormonal regulation and differential expression of AKR1Bs and COX enzymes in adrenal tissue
###end title 9
###begin p 10
###xml 168 174 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 258 265 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g001">Fig. 1A</xref>
###xml 678 682 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ragazzon1">[31]</xref>
###xml 1263 1269 1259 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1407 1413 1399 1401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 1351 1356 <span type="species:ncbi:10090">mouse</span>
We first investigated the effect of modulations of the hypothalamo-pituitary-adrenal (HPA) axis on the capacity of mouse adrenal glands to synthesise and respond to PGF2alpha. For this, whole adrenal protein extracts were submitted to western blot analysis (Fig. 1A). As expected, the level of StAR protein (an ACTH-regulated marker of steroidogenic activity) was decreased under dexamethasone-mediated HPA axis blockade (low plasma ACTH) and progressively restored 17 h after the injection of exogenous ACTH. As previously described, the levels of the ACTH-responsive aldose reductase-like AKR1B7 followed the same pattern, confirming the efficiency of the hormonal treatments [31]. By contrast, AKR1B3 and AKR1B8 proteins were unresponsive to any of the treatments and exhibited constitutive expressions. Interestingly, the rate-limiting enzymes of the prostaglandins synthesis pathway, COX1 and COX2, were both expressed in the adrenals but showed very different hormonal sensitivity. COX1 was constitutively expressed. By contrast, COX2 was undetectable in basal condition. It was strongly stimulated, 2 h after ACTH injection. This stimulation was transient, as shown by the reduction of COX2 accumulation 17 h after ACTH administration. In contrast, the PGF2alpha receptor FP was constitutively expressed in the adrenal. These data suggest that mouse adrenal glands have the capacity to synthesize PGF2alpha in either a constitutive or an ACTH-dependent manner. The presence of FP indicates that they might be able to respond to this signal directly.
###end p 10
###begin title 11
Hormonal regulation and differential expression of AKR1Bs, COXs and FP receptor proteins in adrenal glands.
###end title 11
###begin p 12
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 575 576 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 940 941 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 943 946 939 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 961 962 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1248 1249 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1251 1254 1243 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bar</italic>
###xml 1269 1368 1257 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, artery, M, medulla, ZG, zona glomerulosa, ZF, zona fasciculata, ZR, zona reticularis, C, capsule</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 625 630 <span type="species:ncbi:10090">mouse</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 1015 1020 <span type="species:ncbi:9606">human</span>
###xml 1058 1063 <span type="species:ncbi:9606">human</span>
A, Differential expression of AKR1Bs, COXs and FP receptor proteins in response to ACTH in mouse adrenal glands. Protein extracts (30 microg/lane) from pooled adrenal glands (3 to 6 animals per condition) treated with vehicle alone (5 days, control), dexamethasone (5 days, dex) or dexamethasone (5 days) plus ACTH for time ranging from 2 to 17 h (dex ACTH) were subjected to western blot analysis. Molecular weight markers are shown on the right. COX2 multiple molecular species are a consequence of the heterogeneous glycosylation of the protein (ns, non specific signal). B, Immunolocalization of AKR1B7, COX2 and StAR in mouse adrenal sections. Sections of adrenal glands from male mice treated 5 days with vehicle (control), 5 days with dexamethasone (dex) or with dexamethasone plus ACTH for the last 6 h (dex + ACTH) were immunostained with anti-AKR1B7 (L3 antiserum), anti-COX2 and anti-StAR (steroidogenic cell marker) antibodies (B, bar, 100 microm). C, immunolocalization of AKR1B1, COX2, TH and StAR in human adrenal sections. Sections of normal human adrenal glands were incubated with anti-AKR1B1 (L3 antiserum), anti-COX2, anti-StAR (steroidogenic cell marker) and anti-tyrosine hydroxylase (TH) (chromaffin cell marker) antibodies (C, bar, 200 microm). A, artery, M, medulla, ZG, zona glomerulosa, ZF, zona fasciculata, ZR, zona reticularis, C, capsule.
###end p 12
###begin p 13
###xml 115 122 115 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g001">Fig. 1B</xref>
###xml 167 183 167 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zona fasciculata</italic>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g001">Fig. 1B</xref>
###xml 778 785 778 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g001">Fig. 1C</xref>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 610 615 <span type="species:ncbi:9606">human</span>
Expression of AKR1B7, AKR1B1 and COX2 in mouse and human adrenal glands was then analysed by immunohistochemistry (Fig. 1B). AKR1B7 was detected at high levels in the zona fasciculata of the cortex in basal conditions. This level was decreased upon dexamethasone treatment. AKR1B7 staining increased dramatically and expanded throughout the whole cortex in the presence of ACTH (Fig. 1B). StAR protein had a similar expression pattern, although it spanned the entire cortex irrespective of the hormonal status. In contrast, COX2 positive cells were only found in the adrenal cortex of ACTH-stimulated mice. In human adrenal sections, AKR1B1 and COX2 were restricted to the steroidogenic cells of the cortex (StAR-positive cells) and were absent from the chromaffin cells of the medulla (tyrosine hydroxylase positive cells) (Fig. 1C).
###end p 13
###begin p 14
###xml 74 80 74 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 250 256 246 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2</xref>
###xml 397 404 393 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2A</xref>
###xml 1039 1046 1035 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2B</xref>
###xml 1365 1372 1361 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2C</xref>
###xml 361 367 <span type="species:ncbi:10090">murine</span>
###xml 662 668 <span type="species:ncbi:10090">murine</span>
###xml 1351 1354 <span type="species:ncbi:10116">rat</span>
In order to define which of the adrenal cell types was responsible for PGF2alpha production and which cell type could respond to this signal, we performed western blot experiments with both steroidogenic cortical and medullary chromaffin cell lines (Fig. 2). In contrast with whole adrenal protein extracts (ad.), both FP receptor and COX1 were absent from the murine Y1 adrenocortical cell line (Fig. 2A). In these cells, AKR1B3 and AKR1B8 were constitutively expressed. Remarkably, COX2 and AKR1B7 levels showed parallel time-dependent increases upon forskolin treatment, an activator of cAMP synthesis that stimulates steroidogenesis and StAR expression. The murine MPC862L chromaffin cell line was cultured in the absence or in the presence of dexamethasone in order to mimick the known stimulatory action of glucocorticoids on catecholamine production. In contrast with cortical cells, chromaffin MPC862L cells expressed constitutive high levels of FP receptor and COX1 whereas COX2 was either absent or expressed at very low levels (Fig. 2B). The aldose reductase AKR1B3 was constitutively expressed in these cells whereas AKR1B7 and AKR1B8 were undetectable. We confirmed the mutually exclusive expression of AKR1B7 (cortical cells) and FP receptor (chromaffin cells) by western blots analyses performed on primary cell cultures from dispersed rat adrenals (Fig. 2C).
###end p 14
###begin title 15
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
Differential expression of AKR1Bs, COXs and FP receptor proteins in cell cultures from adrenal cortex and from adrenal medulla.
###end title 15
###begin p 16
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 634 637 <span type="species:ncbi:10116">rat</span>
A, Time-dependent response to 10-5 M forskolin treatment of StAR, AKR1Bs, COXs and FP receptor proteins levels in adrenocortical Y1 cell line was analyzed by western blot. Whole adrenal protein extract was used as a positive control, (ad.). B, Expression levels of AKR1Bs, COXs and FP receptor proteins were analyzed by western-blot in the chromaffin MPC862L cell line either untreated (ctrl) or treated with 10-6 M dexamethasone (dex) for 12 h. These levels were compared to the levels observed in Y1 cells stimulated by 10-5 M forskolin (Fsk) for 6 h (ns, non specific signal). C, FP receptor expression in primary cell cultures of rat adrenal cortical and medullary cells. AKR1B7 and TH positive signals were used as markers of steroidogenic and chromaffin identity, respectively. Molecular weights are indicated on the right.
###end p 16
###begin p 17
###xml 241 247 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Altogether our data demonstrated that there was a coordinated cell-specific expression of COX2 and AKR1B7/B1 in the steroidogenic cells of the adrenocortical cortex. This suggested that this part of the gland had the potential to produce PGF2alpha under cAMP/ACTH control.
###end p 17
###begin title 18
Functional coupling between COX2 and AKR1B7
###end title 18
###begin p 19
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Murakami1">[32]</xref>
###xml 199 209 199 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g003">Fig. 3A, B</xref>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g003">Fig. 3A</xref>
###xml 301 307 301 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 417 424 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g003">Fig. 3B</xref>
###xml 456 462 452 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 576 582 568 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 823 827 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Murakami2">[33]</xref>
###xml 829 833 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ueno2">[34]</xref>
###xml 989 996 977 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g003">Fig. 3C</xref>
###xml 1509 1516 1497 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g003">Fig. 3C</xref>
###xml 1590 1594 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Kabututu1">[26]</xref>
###xml 2064 2070 2052 2054 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
In order to assess a functional coupling between COX2 and AKR1B7, we stably transfected plasmids encoding these two enzymes into the HEK293 cell line that is known to be devoid of COX activity [32] (Fig. 3A, B). Expression of COX2 and AKR1B7 was confirmed by western blotting (Fig. 3A). Amounts of PGF2alpha released in the media by HEK293 clones expressing COX2 alone or both COX2 and AKR1B7 were measured by ELISA (Fig. 3B). A low basal production of PGF2alpha was detected in similar amounts in three independent COX2-expressing clones while a 5- to 20-fold increase of PGF2alpha levels was observed in three independent clones upon stable introduction of AKR1B7 expression vector. Functional coupling for prostaglandin synthesis is dependent on a membrane association of both the COX and prostaglandin synthase enzymes [33], [34]. We thus analysed subcellular localization of AKR1Bs and COX by cellular fractionation of Y1 adrenocortical cells in the absence or presence of forskolin (Fig. 3C). As expected, COX2 was only associated with heavy and low membranes fractions in both hormonal conditions and was absent from nuclear extracts or soluble cytosolic fractions. Importantly, the PGF synthases AKR1B7 and AKR1B3 which were previously considered as cytosolic enzymes, colocalized with COX2 in the heavy membranes fraction and to a lesser extent in the light membranes fractions. Whereas AKR1B3 was constitutively present in these two fractions, AKR1B7 was only observed in the presence of forskolin (Fig. 3C). Note that AKR1B8 which was shown to be devoid of PGF synthase activity [26] was found associated with heavy membranes in all conditions. StAR, a mitochondrial protein responsive to cAMP was mainly found associated with the heavy membrane fraction upon forskolin stimulation. On the other hand, the steroidogenic transcription factor SF-1, was found in the nuclear fraction. This validated the subcellular fractionation procedure. Altogether, we concluded that there was a functional cellular coupling between COX2 and AKR1B7 that resulted in PGF2alpha synthesis.
###end p 19
###begin title 20
Functional cellular coupling between COX2 and AKR1B7.
###end title 20
###begin p 21
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 249 255 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 504 510 496 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 587 596 573 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Asterisks</italic>
###xml 657 663 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 693 694 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 705 706 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 713 714 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1013 1015 991 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
A, Western blot analysis of six different HEK293 clones stably transfected with COX2 expression vector in combination with empty vector (COX2, clones 3, 4, 5) or AKR1B7 expression vector (COX2-AKR1B7, clones 3, 7, 14). B, ELISA quantification of PGF2alpha in media from stably transfected HEK293 cell clones, expressing COX2 alone (COX2-3, -4, -5) or in combination with AKR1B7 (COX2-AKR1B7-3, -7, -14). Cells were stimulated for 30 min with 10 microM A23187 ionophore and culture media were used for PGF2alpha quantification. Values were expressed as the mean of 4 experiments +/- S.D. Asterisks point values significantly different from the release of PGF2alpha by the COX2-4 cell clone. *, P<0.05, **, P<0.01. C, Subcellular localization of AKR1B7, AKR1B3, AKR1B8 and COX2 in Y1 adrenocortical cells was analysed by western-blot. Protein extracts (40 microg/lane) from nuclear (Nuc), heavy membrane (HM), light membrane (LM) and cytosolic fractions (Cyt) of Y1 adrenocortical cells untreated or treated with 10-5 M forskolin for 6 h were subjected to western blot analysis. StAR and SF1 signals were used as markers of heavy membrane fraction and nuclear fraction respectively. Molecular weight markers are shown on the right.
###end p 21
###begin title 22
###xml 27 33 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Hormonal sensitivity of PGF2alpha production in adrenocortical cells and the role of AKR1B7
###end title 22
###begin p 23
###xml 180 186 180 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 412 416 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
###xml 653 660 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g004">Fig. 4A</xref>
###xml 709 715 705 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 737 744 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g004">Fig. 4B</xref>
###xml 801 807 793 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 843 849 831 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 977 983 961 963 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1049 1055 1029 1031 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1128 1135 1104 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g004">Fig. 4C</xref>
###xml 1457 1463 1433 1435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1521 1527 1493 1495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1559 1566 1527 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g004">Fig. 4D</xref>
###xml 1685 1691 1653 1655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1090 1093 <span type="species:ncbi:10116">rat</span>
###xml 1137 1140 <span type="species:ncbi:10116">rat</span>
###xml 1360 1363 <span type="species:ncbi:10116">rat</span>
###xml 1376 1381 <span type="species:ncbi:10090">mouse</span>
###xml 1420 1423 <span type="species:ncbi:10116">Rat</span>
We showed that in Y1 adrenocortical cells, COX2 and AKR1B7 were associated in the same membrane fractions under hormonal stimulation. We thus asked whether cAMP would stimulate PGF2alpha production in a manner dependent on the presence of AKR1B7. In order to answer this question we used Y1 cells clones stably transfected with an antisense cDNA targeting AKR1B7 (AS19) or transfected with an empty vector (EV2) [23]. As expected, AKR1B7 was undetectable in the Y1 AS19 clone (antisense). The control EV2 and the antisense AS19 clones had similar levels of expression of AKR1B3, AKR1B8 and COX2 either in basal condition or under forskolin stimulation (Fig. 4A). Both Y1 clones produced similar amounts of PGF2alpha in basal conditions (Fig. 4B). Forskolin treatment induced a two-fold increase in PGF2alpha release by Y1 EV2 cells whereas PGF2alpha production remained at the basal level in the absence of AKR1B7 (Y1 AS19). To confirm that cAMP/ACTH induced an increase in PGF2alpha release in a non-immortalized cell culture model, we analyzed PGF2alpha production in primary cultures of rat adrenocortical cells. As shown in Fig. 4C, rat adrenocortical cells showed a transient stimulation of COX2 expression upon ACTH treatment for 6h. ACTH sensitivity of rAKR1B7 and StAR protein accumulation was similar to that observed in Y1 cells, whereas AKR1B4 (the rat ortholog of mouse AKR1B3) was constitutively expressed. Rat adrenocortical cells produced PGF2alpha in basal condition and showed a 2.5-fold induction of PGF2alpha release upon ACTH stimulation (Fig. 4D). These experiments demonstrated that the AKR1B7 enzyme was responsible for the cAMP/ACTH-stimulated production of PGF2alpha by steroidogenic adrenocortical cells.
###end p 23
###begin title 24
###xml 27 33 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 116 122 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Hormonal sensitivity of PGF2alpha production in rodent adrenocortical cells and involvement of AKR1B7 protein in PGF2alpha production.
###end title 24
###begin p 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 321 327 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 456 458 452 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 480 481 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 615 617 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 642 643 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 672 678 668 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 776 778 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 844 845 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 855 856 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 558 561 <span type="species:ncbi:10116">rat</span>
###xml 701 704 <span type="species:ncbi:10116">rat</span>
A, Western-blot analysis of AKR1Bs and COX2 proteins accumulation in stably transfected Y1 cell clones expressing AKR1B7 (empty vector EV2) or devoid of AKR1B7 (antisense vector AS19) untreated or treated with 10-5 M forskolin (Fsk) for 6 h. Molecular weight markers are shown on the right. B, ELISA quantification of PGF2alpha in media from stably transfected Y1 cell clones expressing AKR1B7 (EV2) or devoid of AKR1B7 (AS19), untreated or treated with 10-5 M forskolin for 6 h. C, Differential expression of AKR1Bs and COX2 proteins in primary cultures of rat cortical cells treated with vehicle (ctrl) or with 10-9 M ACTH for 6 h or 12 h. D, ELISA quantification of PGF2alpha release in media from rat adrenocortical primary cells, cultured in the absence or presence of 10-9 M ACTH for 6 h. Values are the mean of 3 experiments +/- S.D. *, P<0.05, ** P<0.01.
###end p 25
###begin title 26
###xml 11 17 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Role of PGF2alpha in adrenal endocrine functions
###end title 26
###begin p 27
###xml 31 37 31 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2</xref>
###xml 231 237 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 468 474 464 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 567 574 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">Fig. 5A</xref>
###xml 692 698 684 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 781 787 769 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 900 907 884 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">Fig. 5B</xref>
###xml 1030 1032 1014 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1212 1214 1196 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1220 1226 1204 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1283 1289 1263 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1440 1446 1416 1418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1636 1642 1604 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g004">Fig. 4</xref>
###xml 1643 1644 1611 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">5</xref>
###xml 1689 1693 1657 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Bielohuby1">[35]</xref>
###xml 1740 1746 1708 1710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1450 1455 <span type="species:ncbi:10090">mouse</span>
The experiments illustrated in Fig. 2 provided evidence that the FP receptor was absent from steroidogenic adrenocortical cells (either immortalized cells or cells directly dispersed from adrenal cortex). It is thus likely that PGF2alpha secreted by these cells might act as a paracrine factor. We have shown that chromaffin cells constitutively expressed high levels of FP receptor, COX1 and AKR1B3. Consistent with this, the MPC862L chromaffin cell line secreted PGF2alpha into the culture media. This production was insensitive to glucocorticoids (dexamethasone) (Fig. 5A). Glucocorticoids are known stimulators of catecholamine biosynthesis. In order to investigate a possible role of PGF2alpha on glucocorticoid-induced catecholamine release, we looked at the effects of a PGF2alpha analogue (cloprostenol) on the dopamine secretion of MPC862L cells in the absence or presence of dexamethasone (Fig. 5B). As expected, dexamethasone induced a 2-fold increase in dopamine release. Interestingly, treatment with cloprostenol (10-7 M) not only decreased basal dopamine release but also completely antagonized dexamethasone-induced dopamine secretion. The same effect was obtained on dopamine secretion with 2.10-6 M PGF2alpha (data not shown). These data strongly suggested that PGF2alpha was exerting an inhibitory effect on chromaffin cells dopamine release, through an autocrine/paracrine mechanism. The concentration and content of PGF2alpha in mouse adrenal tissue were determined by GC-MS (130+/-38 pmol/g tissue and 456+/-130 fmol per gland, respectively) and were in a similar range to levels measured in cell culture systems (Fig. 4-5). When expressed relative to adrenal volume [35], the physiological tissue concentration of PGF2alpha appeared to be in the microM range.
###end p 27
###begin title 28
###xml 11 17 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Role of PGF2alpha in adrenal endocrine functions.
###end title 28
###begin p 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 30 36 30 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 111 113 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 146 147 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 245 247 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 273 279 269 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 333 335 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 421 422 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 433 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 441 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 531 537 521 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 691 697 665 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 725 726 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 804 810 774 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1018 1024 984 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">Fig. 5</xref>
###xml 1024 1025 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1329 1336 1291 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;0.001</italic>
A, ELISA quantification of PGF2alpha release by chromaffin MPC862L cells untreated (control) or treated with 10-6 M dexamethasone for 12 h (dex). B, HPLC quantification of dopamine secretion by MPC862L cells cultured in absence or presence of 10-7 M cloprostenol (clo) (PGF2alpha analogue) used either alone or in combination with 10-6 M dexamethasone for 12 h (clo+dex). Values are the mean of 3 experiments +/- S.D. *, P<0.05, ** P<0.01. C, Typical perifusion profiles illustrating the effects of increasing concentrations of PGF2alpha (0.1 microM to 10 microM) and cloprostenol (0.1 nM to 1 microM) on corticosterone secretion. Horizontal bars indicate the start point and duration of PGF2alpha or cloprostenol infusions. D, Semi-logarithmic plot showing the effect of increasing concentrations of PGF2alpha and cloprostenol on the inhibition of corticosterone secretion. Results are expressed as a percentage of the basal secretory rate. Experimental values were calculated from data similar to those presented in Fig. 5C. Each curve represents the mean +/- SEM of 6 to 12 independent experiments. After stabilization, the mean secretion rate of corticosterone in basal condition was 251+/-14 pg/min per adrenal. The concentration-response curve was fitted using the Prism program (GraphPad Software, Inc., San Diego, CA). **P<0.001.
###end p 29
###begin p 30
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-EhrhartBornstein1">[36]</xref>
###xml 211 217 211 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g002">Fig. 2</xref>
###xml 233 239 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 381 387 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 479 485 471 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 665 671 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 856 863 840 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">Fig. 5C</xref>
###xml 869 875 853 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 956 963 936 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g005">Fig. 5D</xref>
###xml 1002 1004 982 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1012 1018 992 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1054 1056 1028 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1076 1078 1048 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 1208 1214 1180 1182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1301 1303 1265 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1312 1314 1276 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1332 1333 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1368 1374 1332 1334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1564 1570 1524 1526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 295 298 <span type="species:ncbi:10116">rat</span>
###xml 550 553 <span type="species:ncbi:10116">rat</span>
Cell-cell interactions play a crucial role for maintenance of the homeostasis of adrenal glands (reviewed in [36]). We showed that FP receptor was not expressed in the steroidogenic cells of the adrenal cortex (Fig. 2) and indeed PGF2alpha had no effect on steroidogenic activity of Y1 cells or rat adrenocortical cells in primary cultures (data not shown). This suggested that PGF2alpha could not directly influence cortical cell activity. We thus investigated the effect of PGF2alpha on corticosterone release by setting-up perifusions of isolated rat adrenals, an experimental approach which preserves the architecture of the gland. Various concentrations of PGF2alpha and of its synthetic analogue, cloprostenol were applied during 20 min. Aliquots of the perifused media were collected every 10 min for determination of corticosterone concentrations (Fig. 5C). PGF2alpha and cloprostenol induced a dose-dependent inhibition of corticosterone release (Fig. 5D). The half-maximum effective doses (IC50) of PGF2alpha and cloprostenol were 1.58+/-0.3x10-6 M and 2.51+/-0.2x10-8 M, respectively. These doses were in agreement with physiological contents found in the adrenal tissue. Maximum responses for PGF2alpha (-39.4+/-6.6%) and cloprostenol (-36+/-9.3%) were obtained with concentrations of 3x10-6 M and 10-7 M, respectively (P<0.001). The negative effect of PGF2alpha was restricted to glucocorticoids since we did not observe any effect on aldosterone production (data not shown). Altogether these data demonstrated that physiological concentrations of PGF2alpha exerted an inhibitory effect on the endocrine functions of adrenal glands by inhibiting both catecholamine and corticosterone release.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 3 9 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 167 171 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-McCracken1">[28]</xref>
###xml 187 193 183 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 283 287 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Frungieri1">[37]</xref>
###xml 289 293 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-SuzukiYamamoto1">[38]</xref>
###xml 307 313 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 532 536 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ueno1">[29]</xref>
###xml 538 542 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Fortier1">[30]</xref>
###xml 717 725 705 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 725 729 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Kabututu1">[26]</xref>
###xml 796 802 784 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 937 943 921 923 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
PGF2alpha has been shown to be an essential autocrine/paracrine regulator of ovarian steroidogenesis that initiates luteolysis and parturition in mammals (reviewed in [28]). Recently, PGF2alpha was proposed to exert a repressive effect on testosterone release by testis Leydig cells [37], [38]. Although PGF2alpha has this prominent role in the reproductive function, nothing was known about its possible impact on the adrenal gland. Furthermore, little was known about the biosynthetic enzymes involved in its selective production [29], [30]. In our previous work, we demonstrated that some aldo-keto reductase 1B (AKR1B) subfamily members expressed in the adrenal gland were endowed with high PGF synthase activity in vitro[26]. Our present work provides new insight in the understanding of PGF2alpha biosynthesis and the role of this prostaglandin in the function of the adrenal gland. Indeed, we establish for the first time that PGF2alpha acts as a negative regulator of adrenal endocrine functions and that the coordinate cell-specific regulation of both cyclooxygenases (COX1 and COX2) and aldo-keto reductases of the AKR1B subfamily (AKR1B7, AKR1B1, AKR1B3) could play a pivotal role in the generation of this signal.
###end p 32
###begin p 33
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 198 204 198 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 404 410 400 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 653 657 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1112 1118 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1326 1335 1314 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 1349 1356 1337 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1444 1448 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez2">[24]</xref>
###xml 1678 1684 1666 1668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2202 2206 2186 2190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ichitani1">[39]</xref>
###xml 29 35 <span type="species:ncbi:10090">murine</span>
###xml 594 600 <span type="species:ncbi:10090">murine</span>
###xml 1361 1366 <span type="species:ncbi:9606">human</span>
###xml 1430 1436 <span type="species:ncbi:10090">murine</span>
###xml 1485 1490 <span type="species:ncbi:9606">human</span>
###xml 1613 1618 <span type="species:ncbi:9606">human</span>
###xml 1789 1794 <span type="species:ncbi:9606">human</span>
###xml 1875 1880 <span type="species:ncbi:9606">human</span>
###xml 2005 2013 <span type="species:ncbi:9606">patients</span>
###xml 2126 2129 <span type="species:ncbi:10116">rat</span>
Using in vivo approaches and murine cell culture models, we have demonstrated that both cortical (steroidogenic cells) and medullary (chromaffin cells) compartments of the adrenal gland secreted PGF2alpha although the isoforms of COX and AKR1B involved in this biosynthetic pathway differed by their location and sensitivity to hormones. In good agreement with these differential expression patterns, PGF2alpha secretion was found to be modulated by ACTH in steroidogenic cells and to be constitutive in chromaffin cells. Indeed, steroidogenic cells only expressed COX2 and two isoforms of the murine aldose reductases with patent PGF synthase activity i.e. AKR1B3 and AKR1B7. Among these enzymes, only COX2 and AKR1B7 were up-regulated by cAMP/ACTH. In particular, we found that ACTH induced a rapid (2h) and transient (persisting until 6-7 h and returning to near control level after 17 h) increase in COX2 protein. By contrast, chromaffin cells essentially expressed COX1 and AKR1B3 enzymes in a constitutive manner. Consistent with these observations, we have demonstrated that the cAMP/ACTH induction of PGF2alpha release by steroidogenic cortical Y1 cells, was strictly dependent on the expression of AKR1B7 and resulted from a functional cellular coupling with COX2. These experiments provide evidence that AKR1B7 is a bona fide PGF synthase in vivo. In human, AKR1B1 was previously shown to be functionally related to the murine AKR1B7 [24]. Here, we showed that in the normal human adrenal gland, AKR1B1 and COX2 were co-localized in the steroidogenic cortical cells. Therefore, it seems likely that the human adrenal cortex could also have the potential to produce PGF2alpha in response to ACTH. However, we observed an unexpected sustained expression of COX2 on sections of the human adrenal cortex. Although this might reflect constitutive COX2 expression in the human adrenal cortex, it seems more likely that this high level of COX2 expression reflects the high stress level of hospitalized patients. In this respect and in agreement with our results, stress induced by bacterial lipopolysaccharide injection in rat was shown to trigger a rapid COX2 mRNA expression in the adrenal cortex [39].
###end p 33
###begin p 34
###xml 89 95 89 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 240 246 236 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 273 280 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 313 317 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Wiltbank1">[40]</xref>
###xml 467 473 459 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 548 554 536 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 775 781 759 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 919 925 899 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1115 1121 1091 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1257 1263 1229 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1427 1433 1395 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g006">Fig. 6</xref>
###xml 1582 1588 1550 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1647 1653 1611 1613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1891 1895 1851 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Haidan1">[41]</xref>
###xml 1949 1955 1909 1911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2112 2113 2068 2069 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2222 2226 2178 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Mohn1">[42]</xref>
###xml 2318 2322 2274 2278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Fortier1">[30]</xref>
###xml 2327 2333 2283 2285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2337 2338 2289 2290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2522 2528 2474 2476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2532 2533 2480 2481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2686 2692 2634 2636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2738 2739 2682 2683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2843 2847 2787 2791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Mohn1">[42]</xref>
###xml 2863 2869 2807 2809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 2873 2874 2813 2814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2981 2985 2921 2925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Scher1">[43]</xref>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 292 298 <span type="species:ncbi:9913">bovine</span>
###xml 620 626 <span type="species:ncbi:10090">murine</span>
###xml 659 662 <span type="species:ncbi:10116">rat</span>
###xml 880 886 <span type="species:ncbi:10090">murine</span>
###xml 1022 1025 <span type="species:ncbi:10116">rat</span>
Although both steroidogenic and chromaffin cells of the murine adrenal gland secreted PGF2alpha, we showed that FP receptor expression was restricted to chromaffin cells. Consistent with this observation, high affinity binding sites for PGF2alpha were only detected in the medulla within the bovine adrenal gland [40]. This suggested that both autocrine (within chromaffin cells) and paracrine (between steroidogenic and chromaffin cells) mechanisms were relaying PGF2alpha effects. Our experimental observations confirm this hypothesis. First, PGF2alpha had no effect on steroidogenesis when applied either to isolated murine adrenocortical cell lines or to rat primary cultures (data not shown) as could be expected for cells devoid of FP receptor. Second, by contrast, PGF2alpha repressed both basal and glucocorticoid-induced catecholamine precursor release (dopamine) from a murine chromaffin cell line. Third, PGF2alpha was shown to repress corticosterone release in a dose dependent manner when applied to isolated rat adrenals in perifusion experiments. Based on these experimental data, we propose that PGF2alpha is involved in an intraadrenal regulatory loop that controls corticosterone release. The cortico-medullary interactions mediated by PGF2alpha could be involved in both a paracrine feedback to limit stress response or in a local control of basal steroidogenesis. The proposed mechanisms are illustrated in Fig. 6 and would occur as follows: 1/A stress-induced ACTH surge triggers a transient induction of COX2 that couples with AKR1B7 in order to synthesize PGF2alpha in the steroidogenic compartment. Increased amounts of PGF2alpha inhibit glucocorticoid secretion through an indirect mechanism. This would involve at least repression of catecholamines release by chromaffin cells. These are known to promote the secretion of adrenocortical cells in a paracrine manner [41]. 2/In basal conditions, constitutive secretion of PGF2alpha by chromaffin cells exerts an autocrine control on catecholamines release, thus limiting their paracrine action on adrenal steroidogenesis. By contrast, PGE2 was shown to promote the rapid release of glucocorticoid from isolated adrenal glands upon ACTH stimulation [42]. Hence, our results suggest that in the adrenal gland as in the female reproductive system [30], PGF2alpha/PGE2 exhibit opposite actions with corticostatic/corticotrophic and luteolytic/luteotrophic effects, respectively. But beyond this, our observations highlight an interesting paradox of PGF2alpha/PGE2 in fine tuning adrenal endocrine functions. Glucocorticoids are potent anti-inflammatory steroids. By inhibiting glucocorticoids production, adrenal PGF2alpha limits anti-inflammatory signals, whereas PGE2, a classic pro-inflammatory mediator, increases anti-inflammatory signals by promoting their secretion [42]. Hence, the PGF2alpha/PGE2 paradigm could provide a plausible mechanism to the dichotomous action of PGs on the inflammatory process [43].
###end p 34
###begin title 35
###xml 55 61 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Proposed model to illustrate the integrated role of PGF2alpha and PGFS of the AKR1B family in adrenal endocrine functions and cortico-medullary interactions.
###end title 35
###begin p 36
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 94 100 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 193 199 189 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 235 242 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 382 389 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 501 507 493 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 709 715 697 699 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 914 920 898 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1202 1208 1182 1184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1584 1588 1560 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
Free arachidonic acid (AA) is metabolized into PGH2 by COX enzymes and then converted into PGF2alpha by PGFS of the AKR1B family. FP receptor expression is restricted to the medullary zone. PGF2alpha synthesized in both the cortex and medulla thus signals in an autocrine/paracrine manner on chromaffin cells. This inhibits catecholamines production. Catecholamines produced in the medulla normally stimulate glucocorticoids release by the cortex. Decreased catecholamine production in response to PGF2alpha stimulation thus results in a decrease in glucocorticoids production. The differential expression and regulation of both COX and AKR1B enzymes within the adrenal zones could allow the adjustment of PGF2alpha production to limit stress response or control basal steroidogenesis by finely tuning glucocorticoid secretion. In basal conditions, chromaffin cells of the medullary zone constitutively secrete PGF2alpha, through the functional coupling between COX1 and possibly the PGFS AKR1B3. Under stress conditions, the resulting ACTH surge induces COX2 expression and sustains AKR1B7 levels in the cortex. Here, we demonstrated that the functional coupling between COX2 and AKR1B7 triggers a PGF2alpha surge that could act as a local paracrine feedback to limit catecholamine-mediated glucocorticoid release. After the stress response has ended, COX2 returns to undetectable levels. The coupling between AKR1B7 and COX2 does not take place. AKR1B7 then functions only as a detoxifying enzyme of the harmful aldehydes produced under chronic/basal stimulation of steroidogenesis [23].
###end p 36
###begin p 37
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Sicard1">[44]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Albertin1">[45]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Bornstein1">[46]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Hsu1">[48]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Doghman1">[49]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Charbonneau1">[50]</xref>
###xml 507 513 507 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 632 638 628 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
There are few examples of paracrine/autocrine factors that are involved in a negative control of glucocorticoid production by acting directly on the adrenal glands. These include the NT1-11 neurotensin fragment [44], urotensin-II (U-II) [45], leptin [46]-[48] and the Agouti-related protein (AgRP)[49], [50]. Among these peptides, NT1-11 is not produced by the adrenal and thus acts as an endocrine factor. By contrast, the three others may be synthesized within the gland. It is therefore possible that PGF2alpha-mediated activation of these repressive peptides could constitute an alternative (or a complementary) mechanism to PGF2alpha-mediated inhibitory tuning of glucocorticoid secretion.
###end p 37
###begin p 38
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
###xml 81 87 81 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 257 263 253 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007309-g006">Fig. 6</xref>
###xml 479 480 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 480 481 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 715 719 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
###xml 764 765 756 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 767 768 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 768 769 760 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 782 786 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Kabututu1">[26]</xref>
###xml 1109 1113 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Madore1">[25]</xref>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 1014 1020 <span type="species:ncbi:9913">bovine</span>
###xml 1090 1096 <span type="species:ncbi:9913">bovine</span>
By detoxifying aldehyde by-products of steroidogenesis [23] and by generating PGF2alpha that inhibits adrenal steroidogenesis, AKR1B7 (and possibly AKR1B1 in human) has complementary actions aimed at protecting the endocrine activity of the adrenal cortex (Fig. 6). However, because of the two very different kinetic constants, PGF synthase or isocaproaldehyde reductase activities are likely to be recruited under different circumstances: the low affinity for isocaproaldehyde (Km = 320 microM) combined to the highly cAMP/ACTH-dependent expression of AKR1B7 ensures an efficient reduction of isocaproaldehyde under chronic stimulation of steroidogenesis (high flow of substrate) with a limited risk of saturation [23]; on the other hand the high affinity for PGH2 (Km = 4 microM) [26] combined with the acute cAMP/ACTH-dependent expression of COX2, allows a rapid response to stress. These two faces of a same enzyme are reminiscent of the 20alpha-hydroxysteroid dehydrogenase and PGF synthase activities of the bovine aldose reductase AKR1B5, that converge to initiate luteolysis in the bovine endometrium [25].
###end p 38
###begin p 39
###xml 34 40 34 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 155 161 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 376 382 368 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 502 508 490 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
In summary, we have found that PGF2alpha exerts a negative effect on the endocrine functions of both cortical and medullary zones of the adrenal gland. PGF2alpha-mediated inhibition of glucocorticoid production is indirect and could require the downregulation of catecholamine production. This would then result in downregulation of adrenal steroidogenesis. Alternatively, PGF2alpha could up-regulate the expression of inhibitory peptides that remain to be identified. We provide evidence that this PGF2alpha signal could originate from the differential expression and regulation of COX enzymes and aldo-keto reductases of the AKR1B family.
###end p 39
###begin title 40
Materials and Methods
###end title 40
###begin title 41
Experimental animals and hormonal manipulations
###end title 41
###begin p 42
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 330 336 <span type="species:ncbi:4182">sesame</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Animal studies were conducted in agreement with standards described by the NIH Guide for Care and Use of Laboratory Animals as well as with the local laws and regulations applicable to animal manipulations in France. For hormonal regulation studies, male mice of the B6D2 F1 strain (4-6-months old) were injected sc with vehicle (sesame oil), dexamethasone acetate for 5 days (75 microg twice daily; Sigma-Aldrich Corp., St. Louis, MO), or dexamethasone acetate (5 d) plus ACTH (10 microg/g, ip; Synacthene, Novartis Pharma S.A., Rueil-Malmaison, France) for the last 2 h or 17 h. For immunohistochemistry experiments, male mice were treated as described above, except for ACTH (1.2 U, im, daily, Synacthene, Novartis Pharma S.A., Rueil-Malmaison, France) for the last 6 h.
###end p 42
###begin title 43
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat primary adrenal cells
###end title 43
###begin p 44
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">medulla</italic>
###xml 693 694 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1286 1288 1266 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 1366 1372 1346 1348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 12 16 <span type="species:ncbi:10116">rats</span>
###xml 847 851 <span type="species:ncbi:9913">calf</span>
###xml 870 875 <span type="species:ncbi:9796">horse</span>
Wistar male rats (150-200 g) were killed by decapitation. Adrenals were rapidly removed, and the medulla was separated from the cortex by squeezing the gland gently after removing the capsula. Cortical and medullary tissues were then separately incubated in HBSS for 20 min at 37degreesC in the presence of collagenase type I (Invitrogen, Cergy-Pontoise, France). Dispersed cells were pelleted and the remaining tissues were submitted to 3 or 4 repeated collagenase incubations until digestion was complete. Supernatants of viable cortical cells were pooled and seeded at a density of 500,000 cells/well in poly-D-lysine-coated 6-well plates (Sigma-Aldrich) and maintained at 37degreesC, 5% CO2 in Dulbecco's modified medium (DMEM)/Ham's F12, for 2 days. Medium was supplemented with 100 U/ml penicillin and 100 microg/ml streptomycin, 2.5% fetal calf serum (FCS), 2.5% horse serum (HS) and 1% insulin-transferrin-sodium selenite (ITS; Sigma-Aldrich). Dispersed chromaffin cells were pooled and seeded at a density of 300,000 cells in 6-well plates and maintained in DMEM for 2 days. Medium was supplemented with 100 U/ml penicillin and 100 microg/ml streptomycin and 10% FCS. On the third day, cells were incubated in serum-free medium for 24 hours. Cortical cells were treated with 10-9 M ACTH (Sigma-Aldrich) for 6 h or 12 h and culture media were removed for PGF2alpha determination. Cortical cells and chromaffin cells were collected to perform western-blot experiments as described below.
###end p 44
###begin title 45
HEK293 cell lines expressing COX2 and AKR1B7 by stable transfection
###end title 45
###begin p 46
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Murakami1">[32]</xref>
HEK293 cells were transfected using a COX2 expression plasmid bearing neomycin resistance kindly provided by Dr M Murakami (Showas University, Tokyo, Japan) and clones were selected as previously described [32]. In order to establish cells transfected with both COX2 and AKR1B7, the clone expressing COX2 was transfected with the cDNA encoding AKR1B7 cloned in a pcDNA3.1/hygro vector (Invitrogen) or with the corresponding empty vector using Exgen (Euromedex, Souffelweyersheim, France). Briefly, 5 microg of plasmid were mixed with 20 microL of Exgen in 1 mL of 150 mM NaCl and added to cells at 70% confluence in 100 mm culture dishes. After selection in culture medium supplemented with hygromycin (40 microg/mL) for 4 weeks, single colonies were picked up and expanded. Expression of COX2 and AKR1B7 was assessed by western-blotting as described below.
###end p 46
###begin title 47
Cell line cultures
###end title 47
###begin p 48
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez1">[23]</xref>
###xml 261 262 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 409 411 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 717 721 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Powers1">[51]</xref>
###xml 815 817 803 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 855 857 843 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1144 1145 1120 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Y1 clones stably transfected with empty vector or AKR1B7 antisense cDNA [23] were maintained in DMEM/F12 supplemented with 10% FCS, 2 mM L-glutamine, 100 U/mL penicillin, 100 microg/mL streptomycin and 200 microg/mL G418 sulfate. For experiments, Y1 cells (1x106) were seeded into 6-well plates. The next day, cells were placed in serum-free medium containing G418 sulfate in the absence or the presence of 10-5 M forskolin (Sigma-Aldrich) for 30 min to 6 h. MPC862L cells (kindly provided by Dr J. Powers, Tufts-New England Medical Center, Boston, MA) were maintained in RPMI 1640 supplemented with 10% HS, 5% FCS, 2 mM L-glutamine, 100 U/mL penicillin and 100 microg/mL streptomycin in dishes with collagen coating [51]. For experiments, MPC862L cells were treated in the same serum-free medium with or without 10-6 M dexamethasone (Sigma-Aldrich) or 10-7 M cloprostenol (Sigma-Aldrich) for 12 h. Stable transfected HEK293 cells were maintained in DMEM supplemented with 10% FCS, 2 mM L-glutamine, 100 U/mL penicillin, 100 microg/mL streptomycin, 200 microg/mL G418 sulfate and 20 microg/mL hygromycin. For cell activation, HEK293 cells (1x106) were seeded into 6-well plates. After 2 days, the cells were placed in antibiotics-free medium supplemented with 1% FCS for 24 h. Cells were then stimulated for 30 min with 10 microM A23187 ionophore (Calbiochem, Darmstadt, Germany) in the same medium.
###end p 48
###begin title 49
Subcellular fractionation
###end title 49
###begin p 50
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 298 300 298 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3.</sub>
Y1 cells (6x107) were scraped gently in PBS-10% glycerol (v/v), washed in PBS and resuspended in 1 mL of hypotonic buffer (0.25 M sucrose, 20 mM Tris (pH 7.5), 10 mM KCl, 1.5 mM MgCl2) containing 1 X protease inhibitor cocktail (Complete, Roche Diagnostics, Meylan, France), 1 mM NaF and 1 mM VO4Na3. They were then incubated on ice for 30 min. After homogeneisation with a Dounce homogenizer (200-300 times), the lysate was subjected to centrifugation at 800 g for 5 min. The cytoplasmic supernatant was centrifuged at 10,000xg for 10 min at 4degreesC to obtain the heavy membrane pellet (HM). The remaining supernatant was centrifuged at 130,000xg for 1 hour at 4degreesC to obtain the light membrane pellet (LM) and the cytosolic supernatant. HM and LM fractions were resuspended in 2 volumes of Triton X-100 lysis buffer (150 mM NaCl, 10 mM Tris pH 7.5, 5 mM EDTA and 1% Triton X-100). Forty microg of total protein from each fraction were analyzed by western-blotting as described below.
###end p 50
###begin title 51
Western-blot experiments
###end title 51
###begin p 52
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Ragazzon1">[31]</xref>
###xml 285 289 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Clark1">[52]</xref>
###xml 493 497 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-DeSantaBarbara1">[53]</xref>
###xml 1073 1077 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Morel1">[54]</xref>
###xml 1322 1326 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-LefrancoisMartinez2">[24]</xref>
###xml 134 140 <span type="species:ncbi:9986">rabbit</span>
###xml 183 189 <span type="species:ncbi:9986">rabbit</span>
###xml 218 224 <span type="species:ncbi:9986">rabbit</span>
###xml 259 265 <span type="species:ncbi:9986">rabbit</span>
###xml 291 297 <span type="species:ncbi:9986">rabbit</span>
###xml 324 330 <span type="species:ncbi:9986">rabbit</span>
###xml 360 366 <span type="species:ncbi:9986">rabbit</span>
###xml 393 399 <span type="species:ncbi:9986">rabbit</span>
###xml 468 474 <span type="species:ncbi:9986">rabbit</span>
###xml 501 507 <span type="species:ncbi:9986">rabbit</span>
###xml 853 860 <span type="species:ncbi:9986">rabbits</span>
###xml 963 969 <span type="species:ncbi:10090">murine</span>
###xml 1082 1088 <span type="species:ncbi:9986">rabbit</span>
###xml 1266 1272 <span type="species:ncbi:10090">murine</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
Western-blots were performed as previously described [31]. Blots were incubated overnight at 4degreesC with the following antibodies: rabbit anti-COX1 (Cayman, Ann Arbor, MI, 1:500), rabbit anti-COX2 (Cayman, 1:1000), rabbit anti-FP receptor (Cayman, 1:500), rabbit anti-StAR (1:5000) [52], rabbit anti-AKR1B3 (L5, 1:2000), rabbit anti-AKR1B7/B1 (L3, 1:5000), rabbit anti-AKR1B8 (L7, 1:2000), rabbit anti-Tyrosine Hydroxylase (TH) (Chemicon, Hampshire, UK, 1:10,000), rabbit anti-SF1 (1:2000) [53] or rabbit anti-beta-actin (Sigma-Aldrich, 1:3000). Primary antibodies were detected with a secondary antibody conjugated to peroxidase (PARIS, Compiegne, France, 1:10,000). Peroxidase activity was detected with the enhanced chemoluminescent system (ECL, Perkin-Elmer,Courtaboeuf, France). For the production of antibodies directed against AKR1B isoforms, rabbits were injected with a glutathione S-transferase fusion of the 17 C-terminal amino acid residues of the murine AKR1B3, AKR1B7 and AKR1B8 proteins and the antibodies were obtained and tested as previously described [54]. L7 rabbit antiserum specificity, was increased by incubation on a GSTrap column (GE Healthcare, Orsay, France) harbouring the GST-AKR1B7 fusion protein. L3 antiserum is specific for both murine AKR1B7 and human AKR1B1, as previously described [24].
###end p 52
###begin title 53
Immunohistochemistry experiments
###end title 53
###begin p 54
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 382 386 <span type="species:ncbi:10090">Mice</span>
Human adrenal sections were kindly provided by the Cortico et MEdullosurrenale: Etude des Tumeurs Endocrines (COMETE) network. Adrenal tissue was obtained from normal glands removed during the surgery of adjacent non-endocrine tumours. Informed consent was given for adrenal tissue collection as part of a protocol approved by the Institutional Review Board of the Cochin Hospital. Mice were killed by vertebral dislocation and adrenal glands were immediately removed and fixed in Bouin's solution at 4degreesC overnight. After embedding in paraffin, tissues were sectioned (10 microm) and mounted on slides. Sections were then deparaffinized in toluene and rehydrated in ethanol with increasing concentrations of water. Quenching of endogenous peroxidase activity, incubation with antibodies and peroxidase staining were performed according to the manufacturer's instructions (Vectastain ABC kit and NovaRED substrate kit, Vector Laboratories, Burlingame, CA). Tissue sections were exposed to anti-COX2 antibody (Cayman, 1:250), anti-AKR1B7/B1 antiserum (L3, 1:500), anti-StAR antiserum (1:500) and anti-TH antibody (Chemicon, 1:500) at 4degreesC overnight. Tissues were counterstained with Harry's hematoxyline and mounted with Crystal Mount (Sigma-Aldrich).
###end p 54
###begin title 55
###xml 29 35 29 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Quantification of adrenal PGF2alpha content
###end title 55
###begin p 56
###xml 174 180 172 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1086 1087 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1088 1089 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Quantification was performed on pairs of adrenal glands from nine male mice (4-6 month-old). Individual adrenal weight was 3.5+/-0.6 mg. Deuterated standards (10 ng of d4-PGF2alpha from Cayman) were added to homogenized adrenal tissue samples (2 glands) and acetic acid was added to obtain pH 3. Extraction was performed three times with 4 ml of ethyl acetate. After each extraction, the supernatants containing PGs were pooled and dried under nitrogen. The extracted sample was derivatized into PG-pentafluobenzylesters and separated by TLC with chloroforme/ethanol 93:7 (v/v) as mobile phase. The silica areas containing PGs derivatives of interest was scrapped off and extracted three times with 2 mL of ethyl acetate/methanol 4:1 (v/v). An other derivatization was performed to obtain pentafluorobenzylester-trimetylsilylether derivatives. Products of interest were then analyzed by gas chromatography-mass spectrometry (GC-MS Agilent Technologies). The quantification was done using selected ion monitoring according to the NICI mass spectral data obtained with standards. Ions at m/z 569 versus 573 were monitored for unlabeled and deuterated PGs, respectively.
###end p 56
###begin title 57
###xml 15 21 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
Analysis of PGF2alpha release
###end title 57
###begin p 58
###xml 3 9 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 127 133 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 159 165 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
PGF2alpha release was measured in 6 h or 12 h culture media. Cellular debris were removed by centrifugation at 15,000xg and PGF2alpha was quantified with a PGF2alpha ELISA test kit (Neogen, Lexington, KY) according to the manufacturer's instructions.
###end p 58
###begin title 59
Analysis of catecholamine release
###end title 59
###begin p 60
Dopamine release was measured in 12 h culture media of MPC862L chromaffin line by HPLC analysis with the Chromsystems kit (Munchen, Germany).
###end p 60
###begin title 61
Perifusion experiments
###end title 61
###begin p 62
###xml 18 24 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 166 170 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007309-Contesse1">[55]</xref>
###xml 191 194 <span type="species:ncbi:10116">rat</span>
The effects of PGF2alpha (Sigma-Aldrich) and cloprostenol (Sigma-Aldrich) on corticosterone secretion were studied by a perifusion technique, as described previously [55]. Briefly, slices of rat adrenal cortex were layered between several beds of Bio-Gel P2 (Bio-Rad Laboratories, Inc., Richmond, CA) into perifusion chambers (equivalent of two adrenal glands/chamber). Adrenal tissue was continuously perifused with CO2-saturated HBSS at a constant flow rate (300 microl/min) and temperature (37degreesC). The glands were allowed to stabilize for 5 h to reach a steady-state level of corticosterone secretion, before any test substance was added. After stabilization, the mean secretion rate of corticosterone in basal conditions was 251+/-14 pg/min per adrenal. Test compounds were dissolved in CO2-saturated HBSS immediately before use and infused into the columns at the same flow rate as HBSS alone. This was achieved through a multichannel peristaltic pump (Desaga, Heidelberg, Germany). Effluent fractions were collected every 5 min (1.5 ml/fraction), and the tubes were immediately frozen until corticosterone assay. Corticosterone concentration was determined by RIA, without prior extraction, in 100 microl aliquots from each fraction. Sensitivity thresholds of the assays were 20 pg. The intra- and interassay coefficients of variation were 3 and 6%. Each perifusion pattern was established as the mean profile of corticosteroid production (+/-SEM) calculated from at least six independent experiments. Corticosterone levels were expressed as percentages of the basal values, calculated as the mean of eight samples (40 min), taken just before the infusion of test substances. The concentration-response curves were fitted using the Prism program (GraphPad Software, Inc., San Diego, CA).
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
###xml 7 13 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 117 118 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 135 136 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 362 363 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For PGF2alpha and catecholamines quantification in culture media, statistical analyses were performed by a Student's t test. Values of P<0.05 and 0.01 were considered significant and highly significant, respectively. For corticosterone assay in organ perifusion experiments, statistical significance was assessed by Bonferroni test after one-way ANOVA. Value of P<0.001 was considered highly significant.
###end p 64
###begin p 65
###xml 189 194 <span type="species:ncbi:9606">Human</span>
We thank Angelique De Haze and Jean-Paul Saru for excellent technical assistance. We are also grateful to Christine Puchol, Sandrine Plantade and Khirredine Ouchen for care of the animals. Human adrenal sections were kindly provided by the Cortico et MEdullosurrenale: Etude des Tumeurs Endocrines (COMETE) network. We thank Dr J. Powers (Tufts-New England Medical Center, Boston, MA) for providing the MPC862L cell line and Dr M. Murakami (Showa University, Tokyo, Japan) for the COX2 expression plasmid.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
The aldo-keto reductase superfamily homepage.
###end article-title 67
###begin article-title 68
Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
###end article-title 68
###begin article-title 69
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Aldose reductase-deficient mice develop nephrogenic diabetes insipidus.
###end article-title 69
###begin article-title 70
Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis.
###end article-title 70
###begin article-title 71
Genetic restoration of aldose reductase to the collecting tubules restores maturation of the urine concentrating mechanism.
###end article-title 71
###begin article-title 72
###xml 25 30 <span type="species:ncbi:9606">human</span>
Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.
###end article-title 72
###begin article-title 73
###xml 112 117 <span type="species:ncbi:9606">human</span>
Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands.
###end article-title 73
###begin article-title 74
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Preliminary characterization, androgen-dependence and ontogeny of an abundant protein from mouse vas deferens.
###end article-title 74
###begin article-title 75
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily.
###end article-title 75
###begin article-title 76
A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase.
###end article-title 76
###begin article-title 77
###xml 47 52 <span type="species:ncbi:9606">human</span>
Identification and characterization of a novel human aldose reductase-like gene.
###end article-title 77
###begin article-title 78
###xml 34 39 <span type="species:ncbi:9606">human</span>
Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family.
###end article-title 78
###begin article-title 79
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Androgen regulation of the mRNA encoding a major protein of the mouse vas deferens.
###end article-title 79
###begin article-title 80
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland.
###end article-title 80
###begin article-title 81
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Luteinizing hormone induces mouse vas deferens protein expression in the murine ovary.
###end article-title 81
###begin article-title 82
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Physiological functions and hormonal regulation of mouse vas deferens protein (AKR1B7) in steroidogenic tissues.
###end article-title 82
###begin article-title 83
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Hormonal and developmental regulation of the mouse aldose reductase-like gene akr1b7 expression in Leydig cells.
###end article-title 83
###begin article-title 84
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
###end article-title 84
###begin article-title 85
A novel inhibitory protein in adipose tissue, the aldo-keto reductase AKR1B7: its role in adipogenesis.
###end article-title 85
###begin article-title 86
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 144 150 <span type="species:ncbi:10090">murine</span>
Cyclic AMP regulates expression of the gene coding for a mouse vas deferens protein related to the aldo-keto reductase superfamily in human and murine adrenocortical cells.
###end article-title 86
###begin article-title 87
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells.
###end article-title 87
###begin article-title 88
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 153 157 <span type="species:ncbi:10116">rats</span>
A 77-base pair LINE-like sequence elicits androgen-dependent mvdp/akr1-b7 expression in mouse vas deferens, but is dispensable for adrenal expression in rats.
###end article-title 88
###begin article-title 89
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells.
###end article-title 89
###begin article-title 90
###xml 124 129 <span type="species:ncbi:9606">human</span>
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.
###end article-title 90
###begin article-title 91
###xml 162 168 <span type="species:ncbi:9913">bovine</span>
An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium.
###end article-title 91
###begin article-title 92
Prostaglandin F2{alpha} Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7.
###end article-title 92
###begin article-title 93
Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
###end article-title 93
###begin article-title 94
Luteolysis: a neuroendocrine-mediated event.
###end article-title 94
###begin article-title 95
Coupling between cyclooxygenases and terminal prostanoid synthases.
###end article-title 95
###begin article-title 96
A postgenomic integrated view of prostaglandins in reproduction: implications for other body systems.
###end article-title 96
###begin article-title 97
Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis.
###end article-title 97
###begin article-title 98
Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways.
###end article-title 98
###begin article-title 99
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.
###end article-title 99
###begin article-title 100
Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.
###end article-title 100
###begin article-title 101
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment.
###end article-title 101
###begin article-title 102
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
###end article-title 102
###begin article-title 103
###xml 47 61 <span type="species:ncbi:10036">Syrian hamster</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Cyclooxygenase-2 and prostaglandin F2 alpha in Syrian hamster Leydig cells: Inhibitory role on luteinizing hormone/human chorionic gonadotropin-stimulated testosterone production.
###end article-title 103
###begin article-title 104
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Co-localization of prostaglandin F synthase, cyclooxygenase-1 and prostaglandin F receptor in mouse Leydig cells.
###end article-title 104
###begin article-title 105
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide: in situ hybridization and immunocytochemical studies.
###end article-title 105
###begin article-title 106
###xml 46 52 <span type="species:ncbi:9913">bovine</span>
Prostaglandin F2 alpha receptors in the early bovine corpus luteum.
###end article-title 106
###begin article-title 107
Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells.
###end article-title 107
###begin article-title 108
The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2.
###end article-title 108
###begin article-title 109
The anti-inflammatory effects of prostaglandins.
###end article-title 109
###begin article-title 110
###xml 76 81 <span type="species:ncbi:9606">human</span>
The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells.
###end article-title 110
###begin article-title 111
###xml 61 64 <span type="species:ncbi:10116">rat</span>
Urotensin-II and UII-receptor expression and function in the rat adrenal cortex.
###end article-title 111
###begin article-title 112
Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly.
###end article-title 112
###begin article-title 113
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland.
###end article-title 113
###begin article-title 114
###xml 275 280 <span type="species:ncbi:9606">human</span>
Leptin interferes with adrenocorticotropin/3',5'-cyclic adenosine monophosphate (cAMP) signaling, possibly through a Janus kinase 2-phosphatidylinositol 3-kinase/Akt-phosphodiesterase 3-cAMP pathway, to down-regulate cholesterol side-chain cleavage cytochrome P450 enzyme in human adrenocortical NCI-H295 cell line.
###end article-title 114
###begin article-title 115
###xml 115 121 <span type="species:ncbi:9913">bovine</span>
Agouti-related protein antagonizes glucocorticoid production induced through melanocortin 4 receptor activation in bovine adrenal cells: a possible autocrine control.
###end article-title 115
###begin article-title 116
Central and peripheral interactions between the agouti-related protein and leptin.
###end article-title 116
###begin article-title 117
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
###end article-title 117
###begin article-title 118
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR).
###end article-title 118
###begin article-title 119
###xml 105 110 <span type="species:ncbi:9606">human</span>
Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene.
###end article-title 119
###begin article-title 120
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse seminal vesicle secretory protein of 99 amino acids (MSVSP99): characterization and hormonal and developmental regulation.
###end article-title 120
###begin article-title 121
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 166 171 <span type="species:ncbi:9606">Human</span>
Funding: This work was supported by the Centre National de la Recherche Scientifique (CNRS), Universite Blaise Pascal and Fondation pour la Recherche Medicale (FRM). Human adrenal sections were kindly provided by the Cortico et MEdullosurrenale: Etude des Tumeurs Endocrines (COMETE) network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 123

